HopeStage
Back to all studies
TerminatedNCT00464191

Escitalopram in Depression in bipolarity: a Placebo-controlled Study of Acute and Maintenance Treatment

Medication studyAges 18–70Norway
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Listed locations
NordfjordeidSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2006
Recruitment status
Terminated
Enrollment listed in the registry
150
Sponsor
Nordfjord Psychiatric Centre
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Norway
Age range
From 18 Years to 70 Years
Official registry ID
NCT00464191
Official title
Show the full official title

Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment

Recruitment & locations

Terminated

Nordfjordeid

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Nordfjord Psychiatric Centre.

Does this study involve medication?

Yes. The study involves medication, including escitalopram.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies